Dnatrix Inc
USPTO Trademark & Patent Filings
Trademark applications and grants for Dnatrix Inc. Dnatrix Inc has 2 trademark applications. The latest application filed is for "DNATRIX"
| Patent Application | Date |
|---|---|
| ADENOVIRUS EXPRESSING IMMUNE CELL STIMULATORY RECEPTOR AGONIST(S) 20210301264 - 17/304006 Tufaro; Frank ; et al. | 2021-09-30 |
| TREATMENT OF BRAIN CANCER WITH ONCOLYTIC ADENOVIRUS 20210213079 - 17/193511 FUEYO-MARGARETO; Juan ; et al. | 2021-07-15 |
| COMBINATION THERAPY FOR TREATMENT OF BRAIN CANCERS 20200376050 - 16/997552 TUFARO; Frank ; et al. | 2020-12-03 |
| BIOMARKERS AND COMBINATION THERAPIES USING ONCOLYTIC VIRUS AND IMMUNOMODULATION 20200330533 - 16/917170 TUFARO; Frank ; et al. | 2020-10-22 |
| COMBINATION THERAPY FOR TREATMENT OF BRAIN CANCERS 20190275092 - 16/346310 Tufaro; Frank ; et al. | 2019-09-12 |
Mark Image Registration | Serial | Trademark Application Date |
|---|---|
"DNATRIX" 5015829 86674607 |
DNATRIX 2015-06-25 |
"DNATRIX" 86674620 |
DNATRIX 2015-06-25 |
| NCAGE Code | 5JY93 | DNATRIX, INC |
| CAGE Code | 5JY93 | DNATRIX, INC |
| S.A.M. Registration | 5JY93 [831078428] | DNATRIX, INC |
| DUNS | 831078428 | Dnatrix, Inc |
| SEC | 0001446505 | DNATRIX INC of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 